Abil’s manufacturing facilities have got WHO GMP / NAFDAC / TFDA / Kenya PPB / Uganda NDA approvals and has a capacity of 3.5 billion Tablets & 0.5 billion Capsules per annum. Our new sterile facility is also targeted for USFDA, EU GMP approvals.
We are currently exporting in South East Asian & African countries like Philippines, Vietnam, Thailand, Kenya, Tanzania, Uganda, Ethiopia, South Sudan, Cambodia & more.
Our current focus is on registering our own dossiers in Central America, South America, Caribbean Islands, West Africa and more and are also looking for experienced business partners for distribution and marketing of our manufactured products.
For more information email on email@example.com